Business Wire

PROJECTPLACE

Del
Planview acquires Projectplace – creates global leader in project collaboration, portfolio and resource management

Planview, a US-based global provider of portfolio and resource management software, acquires Projectplace, a Sweden-based leader in project collaboration and one of the world’s first cloud companies. The acquisition will create a new market leader and pioneer the next phase of cloud-based project collaboration and enterprise portfolio and resource management.

“With the acquisition of Projectplace we continue to define a broader vision of portfolio and resource management,” says Greg Gilmore, CEO of Planview. “By bringing these two solutions together, we can help customers – spanning large enterprises to small teams – move their businesses forward by making better use of their limited resources through portfolio, resource, and work management.”

“It is very satisfying to be able to present online collaborators, project managers and enterprise decision makers such a powerful joint offering. Both Projectplace and Planview are pioneers in their respective fields, which makes this a natural and exciting venture. Together, we will provide users with unique solutions and an even greater possibility to grow with us as their business needs grow,” says Johan Zetterström, CEO of Projectplace.

Prior to the acquisition, Projectplace was owned by venture capital firms InnovationsKapital and Via Venture Partners. Terms of the transaction are not disclosed. With the agreement, Projectplace and Planview Enterprise become business lines in the new company, and the two brands will co-exist. The turnover of the new company will be more than USD 125 million.

Quick facts Planview
Global leader in portfolio and resource management in the cloud
Based in Austin, Texas. Offices in France, Germany, Italy, UK, and Australia
Founded in 1989
325 employees
More than 500 customers in 50 countries
Backed by venture capital and private equity firm Insight Venture Partners
Customers span a variety of geographies and industries – Hallmark, Zurich Insurance, Eurotunnel Group, and US Airways

Quick facts Projectplace
A leader in project collaboration tools
Based in Stockholm, Sweden. Offices in Norway, Denmark, the Netherlands, Belgium, UK, Germany and India.
Founded in 1998
170 employees
Close to 1 000 000 users in 150 000 projects
Formerly owned by InnovationsKapital and VIA Venture Partners
Customers span a variety of geographies and industries – ABB, AEG, BP, British National Health Service, British Sky Broadcasting, Carlsberg, Electrolux, Maersk Oil, Sony, Volvo and Zurich Insurance.

Planview is a global leader in portfolio management and project collaboration. From small teams to large enterprises, leaders in every industry rely on the company’s cloud solutions to empower organizations to reach their goals and drive results by optimizing the capacity of their people and financial resources. Planview’s singular focus fuels a deep commitment to innovation and customer success. For more information, visit  www.planview.com www.projectplace.com

Contact:

For more information:
Per Holmlund, PR manager, Projectplace
+46 73 156 03 12, per.holmlund@projectplace.com
or
PR for Projectplace:
Natasha Hill/ Kersti Klami
Octopus group
Tel: +44 (0)845 3707 024
E-mail: projectplace@weareoctopusgroup.net

Link:

ClickThru

Information om Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Følg pressemeddelelser fra Business Wire

Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.

Flere pressemeddelelser fra Business Wire

BeOne Medicines Presents New SEQUOIA Study Results Reinforcing BRUKINSA’s Differentiated Profile with or without Venetoclax in Frontline CLL at ASCO 202531.5.2025 14:00:00 CEST | Press release

BRUKINSA plus venetoclax demonstrated high response rates and a favorable safety profile across CLL patient types in SEQUOIA Arm D, including those with high-risk del(17p) mutational statusAt 5-year follow-up of SEQUOIA Arm C, BRUKINSA monotherapy showed sustained OS and PFS benefit in hard-to-treat del(17p) CLL patients versus historical data BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today will present new data from the Arm C and D cohorts of the pivotal, global Phase 3 SEQUOIA trial of BRUKINSA® (zanubrutinib). The findings underscore the strong and consistent efficacy of BRUKINSA across CLL patient types, including high-risk mutation status. These data will be presented in two rapid oral presentations at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, IL. Data from the Arm D of SEQUOIA demonstrate that treatment with BRUKINSA plus venetoclax has the potential to drive progression-free survival and overall dee

Andersen Consulting tilføjer Stratence Partners30.5.2025 16:07:00 CEST | Pressemeddelelse

Andersen Consulting udvider sin platform med en samarbejdsaftale med Stratence Partners, der er et konsulentfirma med base i Storbritannien, som hjælper globale virksomheder med at øge markedsandele og forbedre rentabiliteten gennem deres ekspertise inden for prisfastsættelse, strategisk optimering, kommerciel effektivitet og digital transformation. Stratence Partners har en resultatorienteret tilgang og er forpligtet på bæredygtig forandring, hvorved de hjælper deres kunder gennem en unik kombination af konsulentbistand, midlertidige ledelsesindsater og oplæringskurser samt deres egne metoder og løsninger inden for datastyring, datavidenskab (AI), værktøjer og systemer. "Samarbejdet med Andersen Consulting er et spændende skridt for vores firma," sagde Fernando Ventureira, administrerende direktør for Stratence Partners. "I vores arbejde med hos ledere over hele verden har vi erfaret, at deres behov rækker ud over strategisk prisfastsættelse og driftsoptimering. Vores kunder værdsætte

You Up? Grindr’s “Right Now” Goes Global30.5.2025 15:00:00 CEST | Press release

More places, more people – Grindr’s real-time hookup feature makes connecting faster than ever Grindr, the Global Gayborhood in Your Pocket™ with more than 14.6M average monthly active users, today announced the global launch of Right Now, their newest intent-based feature designed to instantly connect people looking for immediate encounters. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250530651954/en/ Grindr's Right Now feature. Right Now is a real-time feed—separate from the app’s main grid that displays profiles—where Grindr users can post text and share photos displayed for one hour, letting other like-minded users know exactly what they’re looking for. “Right Now empowers our users to find exactly what they want, when they want it – without the guesswork,” said AJ Balance, Chief Product Officer at Grindr. “We built this intention-based feature based on feedback from our community so they can connect with like-minded

CAR T Vision Coalition Launches with Ambitious Goal to Double Patients Treated with the Curative Potential of CAR T-cell Therapy by 203030.5.2025 14:00:00 CEST | Press release

Only approximately 2 out of 10 people in the US and 3 out of 10 people in Europe with certain rare, advanced blood cancers receive access to CAR T-cell therapy1,2,3New roadmap report aims to inspire collective action of stakeholder groups and invites additional CAR T-cell therapy leaders to join the coalition Today an international coalition announces the launch of CAR T Vision to unite stakeholders around the shared ambition that every eligible patient should have the opportunity for cure with CAR T-cell therapy. By 2030, the aim is to double the proportion of eligible patients treated with CAR T-cell therapy. As outlined in the new roadmap report, the coalition will work to address access challenges and drive meaningful change in the CAR T-cell therapy healthcare ecosystem with a focus on three critical priorities: increasing awareness and understanding of CAR T-cell therapy; expanding resources and capacity to deliver CAR T-cell therapy; and developing sustainable and innovative fin

Indian Educationist Dr. Achyuta Samanta Recognised With Research Institute in His Name at CUNY, USA30.5.2025 11:17:00 CEST | Press release

In a noteworthy development underscoring growing academic collaboration between India and the United States, the City University of New York (CUNY) has launched a dedicated research platform—the Achyuta Samanta India Initiative of the CUNY CREST Institute (ASIICCI). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250529012005/en/ Dr. Milton Santiago, President of Bronx Community College, and Dr. Achyuta Samanta, Founder of KIIT & KISS, jointly inaugurate the Achyuta Samanta India Initiative of CUNY CREST Institute (ASIICCI) with a ribbon-cutting ceremony in New York. Named after Dr. Achyuta Samanta, a noted Indian educationist and social worker, the initiative focuses on academic research in Indian social and educational sectors, with a particular lens on Odisha. This marks one of the rare instances of a living Indian being honoured with such a naming in an American public university system. Dr. Samanta, who hails from Odisha

I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.

Besøg vores nyhedsrum
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye